vwoo0as e atiiitof? wwwERITHRON-lab.com oar fs Inpevaton x Heath, movin or le seuss SRI Leg yale fo GT ke Kap alt dls Fg Shee hed ys lS DALES eal ye oll ot aote Tee vrevneee pte st IMI Thr 922 os Checked By Sh.Baghinin Test Risk Result Unit Reference( Based on Sex/Age) Fasting Blood Glucose (FBG) H 103 me/dL Normal: 70-99 Prediabetes: 100-125 Diabetic 126 Hemoglobin Alc, HPLC 5.2 % <5.6 Normal 5.1-6.4 Pro-diaboties >6.5 Diabetes eAG; Estimated Average Glucose 103 mg/dL, 70-114 Blood Urea Nitrogen 15.2 mgidL, 6.0-21 Creatinine 0.83 mg/dL, 0.59-1.04 Estimated Glomerular Filtration 87.6 mL/min/1 Rate(e¢GFR).CKD-EPI Stage G: Stage G3a: 45-59 Stage G3b; 30-44 Uric Acid 59 mg/dL, ‘Cholesterol Total 199 mg/dl “Desirable: 200 *Moderate Risk: 200-239 “High risk... 240 Triglycerides 134 mg/dl *Desirabl ses 200 *Borderline high: 1.200400 *Blevated: 400 LDL-Cholestrol 106 mgd * Low risk <130 * Borderline: 130-159 * Elevated:>160 HDL-Cholestrol 55 mg/dL. * Low risk >65 * Moderate: 45-65 * High risk <45 LDL:HDL Ratio 1.93 * Low risk: 0.5-3.0 * Moderate: 3.1-6.0 * High risk: >6.0 Remnant Cholestrol (RC) 38 mg/dl *No risk:..<15 *Low-Mediumn risk: 15-27 **Hiigh-Medium risk:27-43 “High risk:~43, Caleium:Total 96 mg/dL, 8.5-10.5 Phosphorus; Inorganic 28 mg/dL, 26-45 ‘Na; Sodium 140 mEqL 136-145, K; Potassium 3.80 mEqL 3.5-5.0 Bilirubin; Total 0.84 mg/dl 0.1-1.2 Bilirubin; Direct 0.25 mg/dL 0-0.3 Bilirubin; Indirect 0.59 mgd! 0.1-1.2atSitistojP Sen sincus SEY! eal Wipale gts CT li 1 Kae ob Sls FY segue scat eet aee bt wae Yee vreivot sts eID T9429 824 Clinical Chemistry fentte ‘Checked By Sh.Baghinia Alanine Aminotransferase 23 UL Aspartate Aminotransferase 22 UL Alkaline Phosphatase 157 UL 06 Tron 87 ped 34 ‘st 12 weeks of pregnant: 42- ‘The last months of pregnant:23-137 For 6 months after childbirth:16-15€ Test Risk Result Unit Reference( Based on Sex/Age) ESR iH 28 mm 0-20 ESR 2 hour H 59 mm 0-30 [wees Result Unit Reference Value [RBCs Result Unit Reference Va WBC 5.83 1OYuL — 3.40-10.40 RBC 5.19 10°6/uL 3.92-5.20 Neutrophil 60.40 % 40-80 Hb 15.5 aH g/dL. 13.00-15.0 Lymphocyte 29.70 % 20.0-51.1 Het 46.0 % 37-49 Monocyte 6.40. % 2-10 MCV, 88.6 i 80-100 Eosinophil 3.00 % 0.0-5.0 MCH 29.8 Ps 27-31 Basophil 0.50 % 0-2 MCHC 33.7 gd 32.3 Neutrophils # 3.53 10/pL —1.50-7.40 RDW-CV 13.1 115-145, Lymphocytes# 1.73 10%uL 0,95-3.90 RDW-SD 43.2 1 20-50 Monocyte # 0.37 10¥pL—0,20-0.81 nRBC % 0.0 % Eosinophil# 0.17 10/L — 0,00-0.50 nRBC # 0.0 10/1. Basophil# 0.03 10%uL 0.00-0.08 [Platelets Result Unit Reference Va Platelet 270 10%mL 150-450 MPV ee fl 6.5-12, PDW 16.3 % 10-20 P-LCR 34.1 % 13-43‘on02 at5iiptojP WWWERTHRON-lab.com e Innovation or Heath Inovaion or Ue osu SIT Lest Lapale po ole 1 Kp lb Sle Fl sgue Sole hd ya ilS AS kal ye old Yeah DLN take WYN shed ele Result Unit Reference( Based on Sex/Age) Vitamin, D3:25 OH. 24.58 ngml Deficient <10 Cholecaleiferol; HPLC Insufficient 10-29 Sufficient 30-100 Potential Intoxication >100 Endocrinology & Immunodiagnostics Test Risk Result Unit Reference Based on Sex/Age) ‘T4;TotalThyroxine-CLIA on ngidl 5,013.0 ‘T3;Triiodothyronine.CLIA 1703 ngidl 80-190 In Pregnancy T3 mostly increases about 1.5 Times than non pregnants ‘TSH. CLIA 2.190 nlUiml, — 0.5-5.5 During pregnancy: First trimester: 0.1 - 2.5 A lot of preanalytical variable such as Drugs (Metformin, Steroids, NSAIDs, OCP, Anti-depressant, Lithium, Inorganic iodides,..) ,Stress, Hospitalization, Pregnancy ,ong fasting, Exercise, Inflamnation, Menstruation,... cause prominent variation in serum TSH level;for more information zeview-ISH pitfall in wwi.erythro lab.com. Ferritin-ECLIA 44.05" ngimL —_Premenopause: 10-100 postmenopause: 20-200 FSHFollicle Stimulating 784 m[UimL, Follicular Phase : 2.8-11.3 Hormone-ECLIA Follicullar Phase, Days 20 3: 3.0-14.4 Mideycle: 5.8-21 Luteal Phase :1.2-9.0 Post menopausal:21.7-153 post menopause (ERT): 9,7-111 oral conteraceptives: up to 4.9 Males : 0.7-11.1 LHLuteinzing Hormone-ECLIA 66.36 miU/mL, Female : Less than 9 years old 0-2.3, FollicularPhase :1.2-12.7 mid-cycle Peak: 15.5-90 Lateal Phase :0.5-14.6 Post menopause Female:15.6 - 72 Males:1-12.5 Boys : 0-7.6‘on02 at5iiptojP WWWERTHRON-lab.com e Innovation or Heath Inovaion or Ue osu SIT Lest Lapale po ole 1 Kp lb Sle Fl sgue Sole hd ya ilS AS kal ye old Yeah DOT nate WYN shed ele Endocrinology & Immunodiagnostics (ny Vitamin B12-ECLIA 323.45 pgml Newborn: 160-1300, Adult: 200-900 Adult>60 ; 110-800 Folic Acid;ECLIA. 10.0 ng/mL, 3.62-25.66 * = Confirmed by Repeated Analysis PETA son Test Risk Result Unit Reference Based on Sex/Age) CRP;C Reactive Protein- 60 mail. <6 Quantitative RE:Rheumatoid 69 Tim. = 20 Factor;Quantitative Risk Result unit Reference( Based on Sex/Age) 129 See Control 12.9 See Activity % 100 % INR 1 Monitoring of oral anti Co.Ther :2.0-3.0:Prevention systemic embolism Prophylaxis venus thrombosis Valvular heart disease 2.5-3.5:Prosthetic heart valves Checked By M.mostehi Test Risk Result Unit Reference( Based on Sex/Age) Uimalysis “Macroscopy Color Yellow Appearance Clear Specific gravity 1.030 1.005-1.030 pH 5.0 5-8 Protein ‘Trace Negative 10mgidl -—-———— Trace 15-30 mg/dl--——-- Positive(+) 35-100 mg/dl-—~- Positive++) 110-250 mg/dl Positivet+++) >250mg/dl --—--- Positive(++++) Ketones, Negvuraaas atSitistojP WWWERTHRON-lab.com oar fs Innovation fr Helh novation fo Le vais Stan OSE Lesh Lape so GUT ote ty Jue Figs Solas hed ye pil LS Aa ye ald 2 tote Te YF ib INNIIMIEN T2422 east continue Checked By M.mostehi Trace Negative 20/ul Trace 20-35/ul-——- Positive(+) 40-50 /ul —- Positive(+) 55-65 iul —- Positivet+++) 70-150 ful -—- Positivet++++) Glucose Neg Bilirubin Neg Urobilinogen Neg Hemoglobin Neg Microscopy WECihpf 3-5 12 RBChpe 23 12 Dysmorphic RBC Neg Squamous EP/apf 59 12 Path cells‘hpf Neg Crystals /hpf Neg, Othersthpf Neg Infection Indicators Bacteria/hpf Neg Negative LeuEsterase Trace Negative Nitrite Neg Mucus Neg e Culture Result No bacterial growth after 48 hrs incubation